It is reassuring that persons with familial hypobetalipoproteinemia, a genetic disorder characterized by reduced Apo B synthesis and life-long depressed LDL-C, enjoy a reduced risk of cardiac disease and a concomitant increase in lifespan despite significant hepatic fat. This evidence concerns the gene APOB and heart disorder.